ArticlePDF Available

Continuous intake of the Chaga mushroom (Inonotus obliquus) aqueous extract suppresses cancer progression and maintains body temperature in mice

Authors:

Abstract and Figures

Aims: Cancer is a leading cause of morbidity and mortality worldwide; therefore, effective measures for cancer prevention and treatment are in constant demand. The extracts of Inonotus obliquus (Chaga mushroom) demonstrate potent anti-tumor activities and have been used to treat cancer in several countries; however, the actual effect and underlying mechanisms are still unclear. In the present study, we aimed to investigate the effects of continuous intake of aqueous extract from I. obliquus on tumor suppression. Main methods: Anticancer activity of the I. obliquus extract was examined in mouse models of Lewis lung carcinoma growth and spontaneous metastasis after 3 weeks of continuous extract intake at the dose of 6 mg/kg/day, which corresponded to that ingested daily with Chaga infusion in Japan. Key findings: The extract of I. obliquus caused significant tumor suppressive effects in both models. Thus, in tumor-bearing mice, 60% tumor reduction was observed, while in metastatic mice, the number of nodules decreased by 25% compared to the control group. Moreover, I. obliquus extract-treated mice demonstrated the increase in tumor agglomeration and inhibition of vascularization. Interestingly, I. obliquus intake decreased body weight in middle-aged mice and increased body temperature in response to light-dark switching in mature adult mice. Furthermore, I. obliquus prevented temperature drop in mice after tumor implantation. Significance: Our findings suggest that the I. obliquus extract could be used as a natural remedy for cancer suppression by promoting energy metabolism.
Content may be subject to copyright.
Continuous intake of the
Chaga mushroom (Inonotus
obliquus) aqueous extract
suppresses cancer progression
and maintains body
temperature in mice
Satoru Arata
a,b,
*, Jun Watanabe
a
, Masako Maeda
c
, Masato Yamamoto
c
,
Hideto Matsuhashi
b
, Mamiko Mochizuki
b
, Nobuyuki Kagami
b
, Kazuho Honda
d
,
Masahiro Inagaki
c
a
Center for Biotechnology, Showa University, Tokyo, Japan
b
Center for Laboratory Animal Science, Showa University, Tokyo, Japan
c
College of Art and Science at Fujiyoshida, Showa University, Tokyo, Japan
d
Department of Anatomy, School of Medicine, Showa University, Tokyo, Japan
* Corresponding author at: Center for Biotechnology, Showa University, 1-5-8 Hatanodai, Shinagawa-ku,
Tokyo 142-8555, Japan.
E-mail address: arata@pharm.showa-u.ac.jp (S. Arata).
Abstract
Aims: Cancer is a leading cause of morbidity and mortality worldwide; therefore,
effective measures for cancer prevention and treatment are in constant demand.
The extracts of Inonotus obliquus (Chaga mushroom) demonstrate potent anti-
tumor activities and have been used to treat cancer in several countries; however,
the actual effect and underlying mechanisms are still unclear. In the present
study, we aimed to investigate the effects of continuous intake of aqueous extract
from I. obliquus on tumor suppression.
Main methods: Anticancer activity of the I. obliquus extract was examined in
mouse models of Lewis lung carcinoma growth and spontaneous metastasis after
Received:
15 March 2016
Revised:
20 April 2016
Accepted:
6 May 2016
Heliyon 2 (2016) e00111
http://dx.doi.org/10.1016/j.heliyon.2016.e00111
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
3 weeks of continuous extract intake at the dose of 6 mg/kg/day, which
corresponded to that ingested daily with Chaga infusion in Japan.
Key findings: The extract of I. obliquus caused significant tumor suppressive
effects in both models. Thus, in tumor-bearing mice, 60% tumor reduction was
observed, while in metastatic mice, the number of nodules decreased by 25%
compared to the control group. Moreover, I. obliquus extract-treated mice
demonstrated the increase in tumor agglomeration and inhibition of vasculariza-
tion. Interestingly, I. obliquus intake decreased body weight in middle-aged mice
and increased body temperature in response to light-dark switching in mature adult
mice. Furthermore, I. obliquus prevented temperature drop in mice after tumor
implantation.
Significance: Our findings suggest that the I. obliquus extract could be used as a
natural remedy for cancer suppression by promoting energy metabolism.
Keywords: Biochemistry, Biological sciences
1. Introduction
Cancer is one of the leading causes of morbidity and mortality worldwide, with
approximately 14 million new cases and 8.2 million cancer-related deaths
documented in 2012 [1]. While discovering novel therapeutics and providing
adequate care to cancer patients is very important for decreasing cancer burden,
prevention is probably a more critical aspect which was somewhat neglected [2].
Cancer prevention through socioeconomic interventions, environmental changes,
and lifestyle modifications could be a solution for reducing constantly increasing
cancer incidence. Recent epidemiological data demonstrate that obesity increases
the risk of cancer development [3]. Cao et al. [4,5] have reported that mice
housing with increased space, physical activity, and social interactions (enriched
environment, EE) which stimulated physical and mental activities, demonstrated
the suppression of both tumor growth and obesity via inhibition of leptin secretion
from white adipose tissue. EE is also known to decrease adiposity, stimulate
energy expenditure, and induce brown-like (beige) cells in white fat [6].
Furthermore, it has been reported that cancer patients are characterized with
hypothermia and hyperglycemia [7] and that physiologic responses to high body
temperature improve the tumor microenvironment [8]. These findings indicate that
the induction of lipid metabolism and maintenance of proper body temperature
could be important aspects in cancer prevention.
Medicinal mushrooms have an established history of use in traditional oriental
therapy and nutritionally functional foods. Inonotus obliquus (Chaga mushroom)
belonging to the family Hymenochaetaceae of Basidiomycetes, preferably grows
on the trunks of mature live birch trees [9]. The extracts of I. obliquus have been
used in China, Korea, Japan, Russia, and the Baltics for their favorable effects on
Article No~e00111
2http://dx.doi.org/10.1016/j.heliyon.2016.e00111
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
lipid metabolism and cardiac function, as well as for anti-bacterial, anti-
inflammatory, anti-oxidant, and anti-tumor activities [9].I. obliquus extracts were
found to inhibit hepatitis C virus [10] and human immunodeficiency virus [11,
12] and demonstrated strong anti-oxidant and immunostimulatory activities in
vitro [13,14]. At the same time, animal studies revealed that aqueous extracts of
I. obliquus exhibited anti-inflammatory effects in experimental colitis [15,16]
and promoted lipid metabolism [17]. Several studies investigated the anti-tumor
activity of the I. obliquus aqueous extract and found that it suppressed the
proliferation [18] and induced apoptosis [19] of various carcinoma cell lines.
Furthermore, the compounds isolated from I. obliquus extracts were shown to
inhibit skin carcinogenesis [20] and tumor growth in Sarcoma-180 cell-bearing
mice [21]. However, despite increasing evidence of anticancer activity exhibited
by the I. obliquus extract and its individual components [9,22], the underlying
mechanisms are still unclear and the effects of I. obliquus on cancer prevention
are not understood.
In this study, we examined anti-cancer effects of the continuous intake of the
I. obliquus extract using mouse models of tumorigenesis and spontaneous
metastasis. The dose of I. obliquus extract (6 mg/kg/day) was calculated based
on the daily intake of the extract as tea infusion in Japan. We also tested the real
time body temperature using an implanted nano-thermometer. This is the first
study showing that continuous intake of the I. obliquus aqueous extract suppresses
cancer progression and maintains body temperature.
2. Material and methods
2.1. Animals
C57BL/6 mice obtained from Japan SLC Inc. (Shizuoka, Japan) at the age of 8
weeks were kept in the room with controlled temperature (23 ± 2 °C) and a 12-h
light/dark cycle (lights on at 8 am). All experimental procedures involving animals
were approved by the Institutional Animal Care and Use Committee of Showa
University (Permit Number: 55019), which operates in accordance with the
Japanese Government for the care and use of laboratory animals.
2.2. Preparation of aqueous extract from I. obliquus
I. obliquus sclerotia were collected from birch trees in Fujiyoshida city,
Yamanashi prefecture, Japan, and identified by Drs. Mashasi Osawa and Hisasi
Shibata of Yamanashi Forest Research Institute, Japan. The material was
powdered and 32.0 g was suspended in 1 L of water, boiled for 90 min to be
concentrated to 200 300 ml. The extract was filtered through filter paper (No.
101, Advantec, Tokyo, Japan) and freeze-dried, yielding 1.3 g (4.1% of raw
Article No~e00111
3http://dx.doi.org/10.1016/j.heliyon.2016.e00111
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
material). It was re-dissolved in sterilized distilled water to the concentration of
2.4 mg/ml and stored at 80 °C as stock solution.
2.3. Cancer cell culture
Lewis lung carcinoma cell line (3LL) was obtained from National Institutes of
Biomedical Innovation (Osaka, Japan) and maintained in RPMI 1640 medium
supplemented with glutamine (2 mM), penicillin (100 U/mL), streptomycin (100 μg/
mL), and 10% (v/v) heat-inactivated FBS (Thermo Fisher, Waltham, MA, USA).
2.4. I. obliquus anticancer activity in mouse models of carcinoma
and spontaneous metastasis
Mice were given water with or without 24 μg/mL extracts from I. obliquus (1% of
stock solution) for 3 weeks before tumor inoculation and throughout the
experimental period; approximately 6 mg/kg of I. obliquus extract was ingested
in 5 ml of drinking water per day. Cancer models were established as described
previously [23]. Briefly, 5 × 10
5
live 3LL cells were suspended in 0.2 ml of serum-
free MEM and injected subcutaneously in the right flanks of mice to develop solid
intra-abdominal tumors (tumor-bearing model) or into the tail vein to produce
colonies of metastatic cells in the lung (spontaneous metastasis model). In the
tumor-bearing model, tumor size was measured with calipers every day and tumor
volume was calculated as (width)
2
× length × 0.52. Mice were sacrificed at day 16
after tumor cell inoculation, and solid tumors were collected and weighted. For
histological examination, some mice were anesthetized at day 7 of cancer cell
implantation by intraperitoneal injection of sodium pentobarbital (50 mg/kg), and
perfused transcardially with saline, followed by 4% paraformaldehyde in 50 mM
phosphate buffer (pH 7.2). Pulmonary nodules in the metastasis model were
counted using 3D lung images acquired by micro-CT and visually confirmed in the
lungs fixed with neutral formalin and observed under a stereomicroscope. For
micro-CT scanning, animals were anesthetized with isoflurane at day 9 after
cancer cell inoculation and analyzed using an R_mCT2 micro-CT scanner
(Rigaku Corporation, Tokyo, Japan) under the following conditions: FOV24, ϕ24
mm × H19 mm; tube voltage, 90 kV; tube current, 160 μA. Some mice were
sacrificed 2 weeks after cancer cell injection, and the extracted lung tissues were
fixed with neutral formalin and used for histology.
2.5. Histochemistry
Tissues were immersed in 20% sucrose in 0.1 M phosphate buffer (pH 7.2) at 4 °C
and embedded in O.C.T. compound (Sakura Finetek, Tokyo, Japan). Frozen
sections were cut with a microtome at the thickness of 8 μm, washed in PBS
(pH 7.2), and stained with Gill's hematoxylin and eosin (HE). For immunostaining,
Article No~e00111
4http://dx.doi.org/10.1016/j.heliyon.2016.e00111
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
tissue sections were treated with 0.3% H
2
O
2
in PBS to quench endogenous
peroxidase activity, blocked in 5% normal horse serum in PBS for 60 min, and
incubated overnight with rat anti-CD31 polyclonal antibodies (1:500; 550274, BD
Biosciences, East Rutherford, NJ, USA) at 4 °C. Sections were washed with PBS
and incubated with biotinylated goat anti-rat IgG (1:200; BA-4001, Vector,
Burlingame, CA, USA) for 2 h at room temperature, followed by the reaction with
avidin-biotin complex solution (Vector) and chromogen diaminobenzidine
(Vector). Images were captured using an AX70 microscope (Olympus, Tokyo,
Japan).
2.6. Body temperature measurement
Mouse body temperature was monitored using the DST nano-T temperature
logger (17 mm × 6 mm, 1 g; STAR ODDI, Gardabaer, Iceland). The loggers were
implanted in the abdomen and body temperature was continuously measured at
30-min intervals.
2.7. Statistical analysis
Unpaired T-test was performed to assess the significance of independent
experiments after statistical outliers were removed using the Smirnoff-Grubbs
rejection test. Three groups (Fig. 5B and C) were compared using one-way
ANOVA with a Tukey multiple comparison test. The Ekuseru-Toukei software
(Social Survey Research Information Co. Ltd., Tokyo, Japan) was used for
statistical analysis. P values <0.05 were considered statistically significant.
3. Results
3.1. I. obliquus extract promoted a decrease of body weight in
old mice
First, we examined the effect of continuous intake of the I. obliquus aqueous
extract on body weight of mature adult mice (1215 weeks) and middle-aged mice
(30 weeks). The results indicated that middle-aged mice lost about 8% of weight
after 17 days of drinking I. obliquus extracts compared to the control group
(Fig. 1A); there was no difference in water intake between the two groups
(Fig. 1B). Interestingly, the I. obliquus extract caused no changes in body weight or
the amount of consumed water in mature adult mice (Fig. 1C and D). These data
suggest that the intake of the I. obliquus extract promoted lipolysis in developed
fatty tissue; therefore, in further experiments we used mature adult mice (1215
weeks) to avoid the influence of body weight difference between control and
treated mice observed prior to tumor implantation on subsequent tumor growth.
Article No~e00111
5http://dx.doi.org/10.1016/j.heliyon.2016.e00111
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
3.2. Continuous intake of the I. obliquus extract slowed tumor
progression in mice with implanted Lewis lung carcinoma cells
To explore whether I. obliquus had the ability to suppress tumor growth, mice
received water supplemented with I. obliquus extract for 3 weeks prior to and 16
days after the implantation of 3LL cells for the development of solid intra-
abdominal tumors. The images of carcinomas from the treated and control mice
showed that the I. obliquus extract suppressed tumor growth (Fig. 2A).
Furthermore, quantitative analysis revealed significant retardation of tumor
development in the I. obliquus group starting from day 14 after cancer cell
implantation (Fig. 2B); at day 16, the average tumor size in the treatment group
was 60.3% less than in the control group (Fig. 2C). These results indicate that
continuous uptake of the I. obliquus extract produced a strong anti-tumor effect.
[(Fig._1)TD$FIG]
Fig. 1. The intake of the I. obliquus extract promoted body weight loss in middle-aged mice. Middle-
aged and mature adult mice received water without (control) or with the I. obliquus extract for the
indicated times and were analyzed for body weight. (A) Body weight of middle-aged mice (weight at
day 0: 37.3 ± 3.5 g and 37.9 ± 5.1 g for the water and I. obliquus group, respectively; n = 45). (B)
Amount of water drunk by middle-aged mice. (C) Body weight of mature adult mice (weight at day 0:
22.7 ± 1.8 g and 23.3 ± 2.1 g for the water and I. obliquus group, respectively; n = 89). (D) Amount of
water drunk by mature adult mice. The data were normalized to the body weight at day 0 and expressed
as the mean ± SD; *P <0.05.
Article No~e00111
6http://dx.doi.org/10.1016/j.heliyon.2016.e00111
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
3.3. I. obliquus extract decreased tumor vascularization
Next, we analyzed the effect of the I. obliquus extract by histochemistry. HE
staining revealed agglomerated tumor morphology and decreased tumor size in
the I. obliquus group (Fig. 3A). Furthermore, immunostaining for CD31, a
marker of vascular endothelial cells, revealed that the presence of CD31-positive
cells in I. obliquus-treated mice tended to decrease compared to the control
group, indicating that tumor vascularization could be suppressed by the intake of
the I. obliquus extract (Fig. 3B). These results suggest that the continuous intake
of the I. obliquus extract could decrease tumor vascularization and, consequently,
suppress cancer progression.
[(Fig._2)TD$FIG]
Fig. 2. The intake of the I. obliquus extract suppressed tumor development in mice implanted Lewis
lung carcinoma cells. Mice drinking water with or without the I. obliquus aqueous extract were injected
3LL cells subcutaneously in the right flanks and analyzed for tumor size. (A) Representative images of
carcinomas. (B) Quantification of tumor size at the indicated times after 3LL cell implantation. (C) The
weight of solid tumors at day 16 after 3LL cell implantation. Each dot represents a single mouse and
lines show mean values (n = 8 per group; *P <0.05).
Article No~e00111
7http://dx.doi.org/10.1016/j.heliyon.2016.e00111
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
3.4. Continuous intake of the I. obliquus extract suppressed
metastasis
To further explore anti-tumor effects of the I. obliquus extract, it was tested in a
model of spontaneous metastasis to lung tissue induced by intravenous injection
[(Fig._3)TD$FIG]
Fig. 3. I. obliquus extract caused tumor agglomeration and suppressed vascularization. 3LL cells were
injected subcutaneously at the left abdomen of mice drinking water with or without the I. obliquus
aqueous and tumors were analyzed by histology 7 days after cells implantation. (A) HE staining. (B)
Immunostaining for CD31.
Article No~e00111
8http://dx.doi.org/10.1016/j.heliyon.2016.e00111
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
of 3LL cells. First, we analyzed lung metastasis under a stereomicroscope 14
days after tumor implantation. As shown in Fig. 4A and B, lung nodules in
I. obliquus-treated mice tended to decrease compared to the control group. Then,
the lungs from animals anesthetized at day 9 after cancer cell inoculation were
analyzed for the number of pulmonary nodules using micro-CT. The results
indicate that the intake of the I. obliquus extract significantly decreased the
number of tumor nodules in the lungs (Fig. 4C and D). Histology analysis (HE
staining) of tumor nodules demonstrated that I. obliquus intake decreased the size
[(Fig._4)TD$FIG]
Fig. 4. I. obliquus extract suppressed metastasis in mice injected with Lewis lung carcinoma cells. Mice
drinking water with or without the I. obliquus aqueous extract received intravenous injection of 3LL
cells. (A) Representative stereomicroscopic images of fixed mouse lungs containing carcinoma nodules.
Arrowheads mark 3LL nodules on the lung. (B) The number of metastatic nodules counted under a
stereomicroscope. Each dot represents a single mouse and lines show mean values (n = 46 per group).
(C) Representative CT images of mouse lungs containing carcinoma nodules. Arrowheads mark 3LL
nodules visible as dents on the lung. (D) The number of nodules measured in CT images of the lungs
extracted at day 9 after cancer cell injection. Each dot represents a single mouse and lines show mean
values (n = 45 per group; *P <0.05).
Article No~e00111
9http://dx.doi.org/10.1016/j.heliyon.2016.e00111
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
and induced agglomerated morphology of tumor nodules (Fig. 5). These data
suggest that continuous intake of the I. obliquus extract could suppress tumor
progression.
3.5. Continuous intake of the I. obliquus extract prevented body
temperature decrease after tumor implantation
We hypothesized that the maintenance of the body temperature could be a key
factor in suppressing tumor development by the I. obliquus extract. To test this
hypothesis, we subcutaneously implanted nano-temperature loggers in the
abdomen and measured the body temperature in a real-time format. Interestingly,
tumor-free mice continuously drinking the I. obliquus extract showed higher body
temperatures at the switch from darkness to light (Fig. 6A). As there was no
difference in water intake between the I. obliquus and control groups (Fig. 1D),
these data suggest that I. obliquus could upregulate energy metabolism. While
body temperature gradually decreased after tumor implantation in the control
group at the light-to-dark switching (Fig. 6B), it was not the case in the group
taking the I. obliquus extract. These data suggest that I. obliquus may suppress
tumor growth by regulating energy metabolism.
[(Fig._5)TD$FIG]
Fig. 5. The intake of the I. obliquus extract agglomerated tumor cells in the mouse model of
spontaneous metastasis. Mice drinking water with or without the I. obliquus aqueous extract received
intravenous injection of 3LL cells. Representative HE-stained images of lung sections 2 weeks after
cancer cell injection are shown.
Article No~e00111
10 http://dx.doi.org/10.1016/j.heliyon.2016.e00111
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
4. Discussion
The results of this study indicate that daily intake of the I. obliquus extract has anti-
cancer effects. We also showed, for the first time, that I. obliquus maintains the
body temperature in a mouse model of tumorigenesis. Although previous studies
[(Fig._6)TD$FIG]
Fig. 6. Continuous intake of the I. obliquus extract prevented body temperature decrease in mice
implanted Lewis lung carcinoma cells. (A) Average body temperature of mice measured from week 2 to
3 after the intake of drinking water without or with the aqueous extract of I. obliquus. (B, C) Average
body temperature of mice receiving water (B) or I. obliquus extract (C) measured 1 week before (0
week), and 1 week and 2 weeks after cancer cell injection. The data are expressed as the mean (n = 3
per group); *P <0.05 versus water (A) or 0 week (B, C).
Article No~e00111
11 http://dx.doi.org/10.1016/j.heliyon.2016.e00111
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
have reported anti-tumor effects of I. obliquus [9,22], most of them analyzed
cancer treatment and not cancer prevention, as I. obliquus extracts were
administered immediately before or after tumor transplantation [19,24,25]. We
hypothesized that long-term continuous intake of the I. obliquus extract could
suppress tumorigenesis by supporting normal metabolic reactions in the
organism, including thermogenesis. Continuous intake of the I. obliquus extract
at the dose similar to that received by Japanese people through daily Chaga tea
drinking (6 mg/kg/day) significantly reduced body weight in middle-aged mice
(Fig. 1A), but not in mature adult mice (Fig. 1C), suggesting that I. obliquus
intake promotes lipolysis in age-accumulated adipose tissue. A previous study
showed that water-soluble components extracted from I. obliquus improved
insulin sensitivity and reduced adiposity in obese mice fed a high-fat diet [17],
suggesting beneficial anti-hyperglycemic effects and lipid metabolism enhance-
ment. Consistent with our result, that study detected no difference in body weight
between control and I. obliquus extract-treated mice fed a normal diet. In view of
the link revealed between obesity and multiple types of cancer [3], continuous
intake of the I. obliquus aqueous extract could have a potential for tumor
suppression by promoting lipid metabolism.
As the next step, we examined the anticancer activity in mice taking the I. obliquus
extracts daily for 3 weeks prior to tumor implantation. As shown in Fig. 2 and
Fig. 3, a significant suppression of cancer development was observed both in the
tumor growth model and spontaneous metastasis model after the ingestion of the
I. obliquus extract at the dose corresponding to human daily uptake. Though
the mechanisms underlying anti-tumor effects of I. obliquus are still unclear,
previous studies suggest that apoptosis-inducing activity, changes in tumor
microenvironemt such as suppression of angiogenesis, and the improvement of
chronic inflammation in adipose tissue could be involved in I. obliquus-mediated
cancer suppression. Thus, oral administration of the I. obliquus aqueous extract
ameliorated acute inflammation in dextran sodium sulfate-induced colitis in mice
[16]. Here, we observed a tendency for tumor cell agglomeration (Fig. 3A and
Fig. 5) and reduced vascularization (Fig. 3B) in mice drinking the I. obliquus
extract, which can be explained by anti-inflammatory effects exerted by I. obliquus
. Metabolic regulation may also be an important aspect of the anti-cancer effects of
I. obliquus. Obesity and hypernutrition may affect different tissues simultaneously
resulting in a systemic increase in non-esterified fatty acids, insulin, glucose,
leptin, and inflammatory cytokines, and decrease in adiponectin [26], which can
directly promote cancer cell survival, proliferation, and malignant progression. We
measured serum levels of glucose, leptin, and adiponectin in mice drinking the
I. obliquus extract; however, no difference was found (data not shown). Further
studies are needed to understand the molecular mechanism underlying I. obliquus
effects.
Article No~e00111
12 http://dx.doi.org/10.1016/j.heliyon.2016.e00111
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
As recent findings revealed a correlation between tumor development and body
temperature [8,27], we measured the body temperature in mice receiving the
I. obliquus extract continuously before and after tumor implantation. The results
revealed a significantly lower body temperature in the control group at the light-to-
dark switching (Fig. 6B), while the body temperature in the I. obliquus group
remained constant. Although there is no direct evidence of causal relationship
between the maintenance of body temperature and tumor suppression, mice
drinking the I. obliquus extract showed higher body temperature before tumor
implantation (Fig. 6A), indicating that the effects occurred prior to tumor
suppression and may be involved in the anti-tumor activity. It has been suggested
that brown adipose tissue (BAT) plays a key role in energy homeostasis and
thermogenesis not only in infants but also in adults [28]. BAT activity is known to
positively correlate with energy expenditure during cold exposure and negatively
with age, body mass index, and fasting glycemia, suggesting the association
between BAT, cold-induced thermogenesis, and energy metabolism [29]. The
increase in the body temperature by I. obliquus may be mediated by BAT activity
and stimulation of lipid metabolism. As hypothermia is known to activate
adipocytes to stimulate tumor growth [30], the effect of I. obliquus on maintaining
the body temperature could play a critical role in tumor suppression. Future studies
addressing metabolic and inflammatory mechanisms underlying the responses of
the tumor microenvironment to I. obliquus are required to substantiate our
conclusions.
5. Conclusion
We showed that the continuous intake of the I. obliquus extract can potentially
suppress cancer development through the maintenance of the body temperature. In
addition, middle-aged mice drinking the I. obliquus extract exhibited body weight
loss. Our findings suggest that the aqueous extract of I. obliquus could be used as a
natural product for cancer suppression and general health care.
Declarations
Author contribution statement
Satoru Arata: Conceived and designed the experiments; Performed the experi-
ments; Analyzed and interpreted the data; Wrote the paper.
Jun Watanabe: Performed the experiments; Wrote the paper.
Masako Maeda, Masato Yamamoto: Contributed reagents, materials, analysis tools
or data.
Hideto Matsuhashi, Mamiko Mochizuki, Nobuyuki Kagami: Performed the
experiments.
Article No~e00111
13 http://dx.doi.org/10.1016/j.heliyon.2016.e00111
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Kazuho Honda: Conceived and designed the experiments.
Masahiro Inagaki: Conceived and designed the experiments; Contributed reagents,
materials, analysis tools or data.
Funding statement
This research did not receive any specific grant from funding agencies in the
public, commercial, or not-for-profit sectors.
Competing interest statement
The authors declare no conflict of interest.
Additional information
No additional information is available for this paper.
References
[1] B.W. Stewart, C.P. Wild, World Cancer Report 2014 (International Agency
for Research on Cancer), World Health Organization, 2014.
[2] R. Geneau, D. Stuckler, S. Stachenko, M. McKee, S. Ebrahim, S. Basu, et al.,
Raising the priority of preventing chronic diseases: a political process, Lancet
376 (2010) 16891698.
[3] M.J. Khandekar, P. Cohen, B.M. Spiegelman, Molecular mechanisms of
cancer development in obesity, Nat. Rev. Cancer 11 (2011) 886895.
[4] L. Cao, M.J. During, What is the brain-cancer connection? Annu. Rev.
Neurosci. 35 (2012) 331345.
[5] L. Cao, X. Liu, E.J. Lin, C. Wang, E.Y. Choi, V. Riban, et al., Environmental
and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer
remission and inhibition, Cell 142 (2010) 5264.
[6] M.J. During, X. Liu, W. Huang, D. Magee, A. Slater, T. McMurphy, et al.,
Adipose VEGF Links the White-to-Brown Fat Switch With Environmental,
Genetic, and Pharmacological Stimuli in Male Mice, Endocrinology 156
(2015) 20592073.
[7] M. Watanabe, K. Miyajima, I. Matsui, C. Tomiyama-Miyaji, E. Kainuma, M.
Inoue, et al., Internal environment in cancer patients and proposal that
carcinogenesis is adaptive response of glycolysis to overcome adverse
internal conditions, Health (Irvine Calif.) 02 (2010) 781788.
Article No~e00111
14 http://dx.doi.org/10.1016/j.heliyon.2016.e00111
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
[8] E.A. Repasky, S.S. Evans, M.W. Dewhirst, Temperature matters! And why it
should matter to tumor immunologists, Cancer Immunol. Res. 1 (2013)
210216.
[9] M.Y. Shashkina, P.N. Shashkin, A.V. Sergeev, Chemical and medicobiolo-
gical properties of chaga (review), Pharm. Chem. J. 40 (2006) 560568.
[10] V.A. Shibnev, D.V. Mishin, T.M. Garaev, N.P. Finogenova, A.G. Botikov, P.
G. Deryabin, Antiviral activity of Inonotus obliquus fungus extract towards
infection caused by hepatitis C virus in cell cultures, Bull. Exp. Biol. Med.
151 (2011) 612614.
[11] T. Ichimura, O. Watanabe, S. Maruyama, Inhibition of HIV-1 protease by
water-soluble lignin-like substance from an edible mushroom, Fuscoporia
obliqua, Biosci. Biotechnol. Biochem. 62 (1998) 575577.
[12] V.A. Shibnev, T.M. Garaev, M.P. Finogenova, L.B. Kalnina, D.N. Nosik,
[Antiviral activity of aqueous extracts of the birch fungus Inonotus obliquus
on the human immunodeficiency virus], Vopr. Virusol. 60 (2015) 3538.
[13] Y. Nakajima, Y. Sato, T. Konishi, Antioxidant small phenolic ingredients in
Inonotus obliquus (persoon) Pilat (Chaga), Chem. Pharm. Bull. 55 (2007)
12221226.
[14] Y.O. Kim, S.B. Han, H.W. Lee, H.J. Ahnb, Y.D. Yoonb, J.K. Jungb, et al.,
Immuno-stimulating effect of the endo-polysaccharide produced by sub-
merged culture of Inonotus obliquus, Life Sci. 77 (2005) 24382456.
[15] S.Y. Choi, S.J. Hur, C.S. An, Y.H. Jeon, Y.J. Jeoung, J.P. Bak, et al., Anti-
inflammatory effects of Inonotus obliquus in colitis induced by dextran
sodium sulfate, J. Biomed. Biotechnol. 2010 (2010) 943516.
[16] S.K. Mishra, J.H. Kang, D.K. Kim, S.H. Oh, M.K. Kim, Orally administered
aqueous extract of Inonotus obliquus ameliorates acute inflammation in
dextran sulfate sodium (DSS)-induced colitis in mice, J. Ethnopharmacol. 143
(2012) 524532.
[17] J.H. Lee, C.K. Hyun, Insulin-sensitizing and beneficial lipid-metabolic effects
of the water-soluble melanin complex extracted from Inonotus obliquus,
Phytother. Res. 28 (2014) 13201328.
[18] S.H. Lee, H.S. Hwang, J.W. Yun, Antitumor activity of water extract of a
mushroom Inonotus obliquus, against HT-29 human colon cancer cells,
Phytother. Res. 23 (2009) 17841789.
[19] M.J. Youn, J.K. Kim, S.Y. Park, Y. Kim, C. Park, E.S. Kim, et al., Potential
anticancer properties of the water extract of Inonotus [corrected] obliquus by
Article No~e00111
15 http://dx.doi.org/10.1016/j.heliyon.2016.e00111
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
induction of apoptosis in melanoma B16-F10 cells, J. Ethnopharmacol. 121
(2009) 221228.
[20] T. Nakata, T. Yamada, S. Taji, H. Ohishi, S. Wada, H. Tokuda, et al.,
Structure determination of inonotsuoxides A and B and in vivo anti-tumor
promoting activity of inotodiol from the sclerotia of Inonotus obliquus,
Bioorg. Med. Chem. 15 (2007) 257264.
[21] M.J. Chung, C.K. Chung, Y. Jeong, S.S. Ham, Anticancer activity of
subfractions containing pure compounds of Chaga mushroom (Inonotus
obliquus) extract in human cancer cells and in Balbc/c mice bearing Sarcoma-
180 cells, Nutr. Res. Pr. 4 (2010) 177182.
[22] F.Q. Song, Y. Liu, X.S. Kong, W. Chang, G. Song, Progress on
understanding the anticancer mechanisms of medicinal mushroom: inonotus
obliquus, Asian Pac. J. Cancer Prev. 14 (2013) 15711578.
[23] Y. Zheng, M. Xu, X. Li, J. Jia, K. Fan, G. Lai, Cimetidine suppresses lung
tumor growth in mice through proapoptosis of myeloid-derived suppressor
cells, Mol. Immunol. 54 (2013) 7483.
[24] J.S. Bae, K.H. Jang, H. Yim, H.K. Jin, Polysaccharides isolated from
Phellinus gilvus inhibit melanoma growth in mice, Cancer Lett. 218 (2005)
4352.
[25] Y.O. Kim, H.W. Park, J.H. Kim, J.Y. Lee, S.H. Moon, C.S. Shin, Anti-cancer
effect and structural characterization of endo-polysaccharide from cultivated
mycelia of Inonotus obliquus, Life Sci. 79 (2006) 7280.
[26] J. Font-Burgada, B. Sun, M. Karin, Obesity and Cancer: The Oil that Feeds
the Flame, Cell Metab. 23 (2016) 4862.
[27] S.D. Hursting, J. Digiovanni, A.J. Dannenberg, M. Azrad, D. Leroith, W.
Demark-Wahnefried, et al., Obesity, energy balance, and cancer: new
opportunities for prevention, Cancer Prev. Res. 5 (2012) 12601272.
[28] N.H. Rogers, Brown adipose tissue during puberty and with aging, Ann. Med.
47 (2) (2015) 142149.
[29] P. Lee, M.M. Swarbrick, K.K.Y. Ho, Brown adipose tissue in adult humans:
A metabolic renaissance, Endocr. Rev. 34 (2013) 413438.
[30] G. Du, B. Zhao, Y. Zhang, T. Sun, W. Liu, J. Li, et al., Hypothermia activates
adipose tissue to promote malignant lung cancer progression, PLoS One 8
(2013) e72044.
Article No~e00111
16 http://dx.doi.org/10.1016/j.heliyon.2016.e00111
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
... After tumor growth (2 weeks after the organoid injection), mice were randomly divided into two groups (Chaga and vehicle groups), each of four mice. Chaga [6 mg/mouse/day (Arata et al., 2016)] or vehicle (1% β cyclodextrin) was orally administered by gavage for 4 weeks. Tumor dimensions were calibrated every week for 4 weeks of administration and their volumes (V) were evaluated as follows: V = 1/2 (L×W 2 ), where L and W are the longest (length) and shortest ...
... In vivo, it also induced a dramatic decline in the Ki67-positive cells and a raise in the TUNEL staining of colonic tumor epithelial cells in mice (Kang et al., 2015). In addition, Chaga exhibited cytotoxic effects through apoptosis induction in breast adenocarcinoma and murine lung tumors (Arata et al., 2016;Zhang et al., 2018). These data collectively indicate that Chaga targets cell cycle and apoptosis pathways to inhibit the growth and proliferation of DBCO. ...
... In the present study, Chaga oral administration significantly reduced volumes and weights of DBCO xenografted tumors in mice (Figure 8). Similarly, Arata et al. (2016) demonstrated that a constant intake of the Inonotus obliquus aqueous extract induced a 60% tumor reduction and a 25% decline in the number of nodules in metastatic tumors compared with the control group in mouse models of Lewis lung carcinoma. In another in vivo study, ergosterol peroxide derived from Chaga suppressed the growth of tumors in the colon of Azoxymethane/Dextran sulfate sodium-treated mice with induction of apoptosis (Kang et al., 2015). ...
Article
Full-text available
Despite its disadvantages, chemotherapy is still commonly used for the treatment of bladder cancer (BC). Developing natural supplements that can target cancer stem cells (CSCs) which cause drug resistance and distant metastasis is necessary. Chaga mushrooms are popular to have several health-promoting and anti-cancer potentials. Organoid culture can recapitulate tumor heterogeneity, epithelial environment, and genetic and molecular imprints of the original tissues. In the previous study, we generated dog bladder cancer organoids (DBCO) as a novel experimental model of muscle-invasive BCO. Therefore, the present study aimed to examine the anti-tumor potentials of Chaga mushroom extract (Chaga) against DBCO. Four strains of DBCO were used in the present study. Treatment with Chaga inhibited the cell viability of DBCO in a concentration-dependent way. Treatment of DBCO with Chaga has significantly arrested its cell cycle and induced apoptosis. Expression of bladder CSC markers, CD44, C-MYC, SOX2, and YAP1, declined in the Chaga-treated DBCO. Also, Chaga inhibited the phosphorylation of ERK in DBCO. Expression of downstream signals of ERK, C-MYC, and Cyclins (Cyclin-A2, Cyclin-D1, Cyclin-E1, and CDK4) was also inhibited by Chaga in DBCO. Interestingly, the combinational treatment of DBCO with Chaga and anti-cancer drugs, vinblastine, mitoxantrone, or carboplatin, showed a potentiating activity. In vivo, Chaga administration decreased tumor growth and weight of DBCO-derived xenograft in mice with the induction of necrotic lesions. In conclusion, Chaga diminished the cell viability of DBCO by inhibiting proliferation-related signals and stemness conditions as well as by arresting the cell cycle. Collectively, these data suggest the value of Chaga as a promising natural supplement that could potentiate the effect of adjuvant chemotherapy, lower its adverse effects, and thus, limit the recurrence and metastasis of BC.
... Whole body Inotodiol Cervical cancer 15 9. ...
Article
Full-text available
One of the most important health issues facing humanity, cancer is a scary disease that demands a proactive approach to treatment. Plants, a source of novel chemical entities and a promising topic for cancer research. Despite its success, chemotherapy has so far had some unfavourable side effects. However, the use of plants and products generated from them is revolutionising the field as a simple, secure, cost-effective, time-saving, environmentally friendly, and less hazardous alternative to traditional treatment procedures. Phytochemicals have selective activities that are targeted towards tumour cells. The complex process known as carcinogenesis involves a number of signalling cascades. Phytochemicals are thought to be attractive prospects for the development of new therapeutics because of their pleiotropic effects on the target event in a number of ways." Researchers are looking at which of these phytochemicals might be possibilities for inhibiting or reducing the growth of cancer cells without causing any unfavourable side effects. There are a lot of phytochemicals and the analogues they were made from that have been identified as potential anticancer therapeutic possibilities. An effort has been made to highlight the most recent developments and noteworthy accomplishments in phytomolecule-based cancer therapies that target nuclear and cellular components through this succinct overview.
... Previous research, both in vitro and in vivo, has explored the anticancer potential of chaga mushroom extracts, as per Abugomaa et al., (2023). Their findings indicated these extracts' ability to inhibit a variety of cancer cell lines Lee et al., (2021), induce apoptosis or programmed cell death in cancer cells Su et al., (2020), and suppress tumor expansion and metastasis in animal models Arata et al., (2016). ...
Article
Full-text available
The present study investigates the bioactive properties of the Ethyl Acetate Extract of Inonotus obliquus (EAEIO), sourced from the Chaga mushroom. Traditionally used in medicine, this mushroom is increasingly recognized for its potent antimicrobial and anticancer benefits. Our analysis sought to explore the impact of EAEIO on four diverse bacterial strains: Escherichia coli ATCC25922, Bacillus cereus EMCC1080, Pseudomonas aeruginosa ATCC10145, and Listeria monocytogenes NCTC7973, employing the disc diffusion method. We also investigated the potential cytotoxic effect of EAEIO on MCF7 breast cancer cells, HCT16 colon cells, and normal BHK cells using the MTT assay. Our results underscore the effective antimicrobial properties of EAEIO, evidenced by inhibition zones between 16 mm to 28 mm and minimum inhibitory concentrations (MICs) ranging from 6.25 µg/mL to 1.563 µg/mL. In addition, the EAEIO demonstrated remarkable anticancer activity against MCF7 and HCT16 cell lines, with IC50 values of 7.56 µg/mL and 11.2 µg/mL, respectively. To conclude, EAEIO - the Ethyl Acetate Extract of the Chaga mushroom, exhibited significant antimicrobial and anticancer properties while showing no toxic effect on BHK cells. These observations suggest EAEIO's potential as a valuable natural resource for antimicrobial and anticancer treatments. However, further research is essential to verify the safety and efficacy of EAEIO in cancer and infectious disease management.
... In the Lewis lung mice carcinoma model, the extract of chaga decreased the size of tumors by 60%, and, in parallel, reduced the number of metastatic nodules [453]. ...
Article
Full-text available
Traditional herbal medicine (THM) is a “core” from which modern medicine has evolved over time. Besides this, one third of people worldwide have no access to modern medicine and rely only on traditional medicine. To date, drugs of plant origin, or their derivates (paclitaxel, vinblastine, vincristine, vinorelbine, etoposide, camptothecin, topotecan, irinotecan, and omacetaxine), are very important in the therapy of malignancies and they are included in most chemotherapeutic regimes. To date, 391,000 plant and 14,000 mushroom species exist. Their medical and biochemical capabilities have not been studied in detail. In this review, we systematized the information about plants and mushrooms, as well as their active compounds with antitumor properties. Plants and mushrooms are divided based on the regions where they are used in ethnomedicine to treat malignancies. The majority of their active compounds with antineoplastic properties and mechanisms of action are described. Furthermore, on the basis of the available information, we divided them into two priority groups for research and for their potential of use in antitumor therapy. As there are many prerequisites and some examples how THM helps and strengthens modern medicine, finally, we discuss the positive points of THM and the management required to transform and integrate THM into the modern medicine practice.
... While chaga mushroom was earlier reported to have improved body weight of mice models of obesity and suppression of inflammation in the liver and spleen of high-fat diet-induced obesity in mice [Na et al., 2019]. It also maintained the body weight in mouse models of Lewis lung carcinoma as well as it suppressed the growth and spontaneous metastasis of tumor in mice [Arata et al., 2016]. Thus, chaga mushroom extract acting to restore the body weight loss in mice exposed to MC-LR is an important preliminary preventive signature in inflammatory liver diseases. ...
Article
Full-text available
Environmental toxicants like microcystins are known to adversely impact liver physiology and lead to the increased risk for abnormal liver function and even liver carcinoma. Chaga mushroom (Inonotus obliquus) is reported for various properties mainly antibacterial, antiallergic, anti-inflammatory, antioxidant, and anticancer properties. This study was aimed to assess the effect microcystin (MC-LR) on histopathology of liver in mice and a preventive measure by using aqueous extract of Inonotus obliquus (IOAE). Adult Balb/c mice were administered with MC-LR at 20 μg/kg body weight, per day, intraperitoneal (i.p.) for 4 weeks. IAOE was treated to one group of MC-LR mice at 200 mg/kg body weight, per oral, for 4 weeks. Histological staining for liver structural details and biochemical assays for functions were assessed. The results of the study showed that MC-LR drastically reduced the body weight of mice which were restored close to the range of control by IAOE treatment. MC-LR exposed mice showed 1.9, 1.7 and 2.2-fold increase in the levels of SGOT, SGPT and LDH which were restored by IOAE treatment as compared to control (one-fold). MC-LR exposed mice showed reduced level of GSH (19.83 ± 3.3 μM) which were regained by IOAE treatment (50.83 ± 3.0 μM). Similar observations were noted for catalase activity. Histological examinations show that MC-LR exposed degenerative changes in the liver sections which were restored by IAOE supplementation. The immunofluorescence analysis of caspase-3 counterstained with DAPI showed that MC-LR led to the increased expression of caspase-3 which were comparatively reduced by IAOE treatment. The cell viability decreased on increasing the concentration of MC-LR with 5% cell viability at concentration of 10 μg MC-LR/mL as that of control 100% Cell viability. The IC50 was calculated to be 3.6 μg/ml, indicating that MC-LR is chronic toxic to AML12 mouse hepatocytes. The molecular docking interaction of NF-κB-NIK with ergosterol peroxidase showed binding interaction between the two and showed the plausible molecular basis for the effects of IAOE in MC-LR induced liver injury. Collectively, this study revealed the deleterious effects of MC-LR on liver through generation of oxidative stress and activation of caspase-3, which were prevented by treatment with IOAE.
... Different functional bioactive compounds Cardiac glycosides Anthraquinones, avonoids, Tannins, Terpenoids and proteins were reported from mushrooms [28,29,30]. Water extract of Chaga mushrooms contains potent anti-cancer compounds [31]. Mushrooms are gaining importance by researchers worldwide due to their nutritional and pharmacological importance [32,33]. ...
Preprint
Full-text available
Wild edible mushrooms (WEM) are economically significant and used in traditional medicines worldwide. The region of Jammu and Kashmir (Western Himalayas) is enriched with the diversity of edible mushrooms, collected by the rural people for food and income generation. This is the first detailed study on diversity and ethno-medicinal uses of mushrooms from the State of Jammu and Kashmir. Methods: Consecutive surveys were conducted to record ethno-mycological diversity and socio-economic importance of wild edible mushrooms value chain in rural areas of Azad Jammu and Kashmir during 2015-2020. Data were collected with a semi-structured questionnaire having a set of questions on indigenous mycological knowledge and collection and retailing of wild edible mushrooms. A total of 923 informants from the study area provided results identifying the gender, type of mushroom species, medicinal uses, and marketing of mushrooms. Principal component analysis (PCA) was also applied to the data set to analyse the relationship between species distribution, the underlying environmental factors and habitat types. PCA identified the major species specific to the sites and put them close to the sites of distribution. Results: A total of 131 mushroom species were collected and identified during 2015-2020 from the study area. One hundred and one species of mushrooms were reported new to the State of Jammu and Kashmir. The dominant mushroom family was Russullaceae with 23 species followed by Agaricaceae, 16 species. Major mushroom species identified and grouped by the PCA were Coprinus comatus, Lactarius sangufulus, Amanita fulva, Armillaria gallica, Lycoperdon perlatum, Lycoperdon pyriforme, and Russula creminicolor. Sparassis crispa, Pleurotus sp and Laetiporus sulphurous were recorded most edible and medicinally significant fungi. Morels were the most expensive and medicinally important among all harvested macro-fungal species. These were reported to use against the common ailments and various health problems. Conclusions: Collection and retailing of WEM contribute to improve the socioeconomic status, providing alternative employment and food security to rural people of the area. These mushrooms are used as a source of food and traditional medicines among the rural informants and could be used a potential source of antibacterial and anticancer drugs in future.
Article
The human uses of mushrooms and cultured mycelium products for nutrition and medicine are detailed and supported by available human studies, which in many cases are clinical trials published in peer-reviewed journals. The major medically active immunomodulating compounds in the cell walls-chitin, beta-glucans, and glycoproteins, as well as lower weight molecules-nitrogen-containing compounds, phenolics, and terpenes-are discussed in relation to their current clinical uses. The nutritional content and foods derived from mushrooms, particularly related to their medical benefits, are discussed. High-quality major nutrients such as the high amounts of complete protein and prebiotic fibers found in edible and medicinal fungi and their products are presented. Mushrooms contain the highest amount of valuable medicinal fiber, while dried fruiting bodies of some fungi have up to 80% prebiotic fiber. These fibers are particularly complex and are not broken down in the upper gut, so they can diversify the microbiome and increase the most beneficial species, leading to better immune regulation and increasing normalizing levels of crucial neurotransmitters like serotonin and dopamine. Since the growth of medicinal mushroom products is expanding rapidly worldwide, attention is placed on reviewing important aspects of mushroom and mycelium cultivation and quality issues relating to adulteration, substitution, and purity and for maximizing medicinal potency. Common questions surrounding medicinal mushroom products in the marketplace, particularly the healing potential of fungal mycelium compared with fruiting bodies, extraction methods, and the use of fillers in products, are all explored, and many points are supported by the literature.
Article
Full-text available
Cancer is a prominent cause of mortality globally, and it becomes fatal and incurable if it is delayed in diagnosis. Chemotherapy is a type of treatment that is used to eliminate, diminish, or restrict tumor progression. Chemotherapeutic medicines are available in various formulations. Some tumors require just one type of chemotherapy medication, while others may require a combination of surgery and/or radiotherapy. Treatments might last from a few minutes to many hours to several days. Each medication has potential adverse effects associated with it. Researchers have recently become interested in the use of natural bioactive compounds in anticancer therapy. Some phytochemicals have effects on cellular processes and signaling pathways with potential antitumor properties. Beneficial anticancer effects of phytochemicals were observed in both in vivo and in vitro investigations. Encapsulating natural bioactive compounds in different drug delivery methods may improve their anticancer efficacy. Greater in vivo stability and bioavailability, as well as a reduction in undesirable effects and an enhancement in target-specific activity, will increase the effectiveness of bioactive compounds. This review work focuses on a novel drug delivery system that entraps natural bioactive substances. It also provides an idea of the bioavailability of phytochemicals, challenges and limitations of standard cancer therapy. It also encompasses recent patents on nanoparticle formulations containing a natural anti-cancer molecule.
Article
Full-text available
Microenvironment has been increasingly recognized as a critical regulator of cancer progression. In this study, we identified early changes in the microenvironment that contribute to malignant progression. Exposure of human bronchial epithelial cells (BEAS-2B) to methylnitrosourea (MNU) caused a reduction in cell toxicity and an increase in clonogenic capacity when the temperature was lowered from 37°C to 28°C. Hypothermia-incubated adipocyte media promoted proliferation in A549 cells. Although a hypothermic environment could increase urethane-induced tumor counts and Lewis lung cancer (LLC) metastasis in lungs of three breeds of mice, an increase in tumor size could be discerned only in obese mice housed in hypothermia. Similarly, coinjections using differentiated adipocytes and A549 cells promoted tumor development in athymic nude mice when adipocytes were cultured at 28°C. Conversely, fat removal suppressed tumor growth in obese C57BL/6 mice inoculated with LLC cells. Further studies show hypothermia promotes a MNU-induced epithelial-mesenchymal transition (EMT) and protects the tumor cell against immune control by TGF-β1 upregulation. We also found that activated adipocytes trigger tumor cell proliferation by increasing either TNF-α or VEGF levels. These results suggest that hypothermia activates adipocytes to stimulate tumor boost and play critical determinant roles in malignant progression.
Article
Full-text available
In a series of our recent studies, stress was found to induce simultaneously hypothermia and hyperglycemia. These conditions are beneficial to obtain prompt force which depends on the glycolysis pathway and to escape emergency. Since we have noticed that such conditions resemble the internal environment seen in some cancer patients, it was investigated whe- ther such conditions were accompanied with other patients. We selected patients with early and advanced cancer. Body temperature and other parameters including blood gas contents were examined. A difference was seen in body temperature, namely, many patients showed hypothermia, irrespective of cancer stages. Fur- ther characterization of other parameters show- ed that hypothermia and hyperglycemia existed in many patients. They had immunosuppressive state and anemia. Blood gas analysis showed that oxygen contents were low and carbon dioxide contents were high in patients. These results suggest a possibility that the internal environment seen in patients is responsible to induce onset of disease and to maintain their cell growth, because cancer cells have an energy system of predominant glycolysis. Although hypothermia, hypoxia and hyperglycemia are important to activate the glycolysis pathway and to escape from emergency, such responses suppress the mitochondrial pathway for long span and may result in carcinogenesis.
Article
Full-text available
Cancer is a leading cause of death worldwide. Recently, the demand for more effective and safer therapeutic agents for the chemoprevention of human cancer has increased. As a white rot fungus, Inonotus obliquus is valued as an edible and medicinal resource. Chemical investigations have shown that I. obliquus produces a diverse range of secondary metabolites, including phenolic compounds, melanins, and lanostane-type triterpenoids. Among these are active components for antioxidant, antitumoral, and antiviral activities and for improving human immunity against infection of pathogenic microbes. Importantly, their anticancer activities have become a hot recently, but with relatively little knowledge of their modes of action. Some compounds extracted from I. obliquus arrest cancer cells in the G0/G1 phase and then induce cell apoptosis or differentiation, whereas some examples directly participate in the cell apoptosis pathway. In other cases, polysaccharides from I. obliquus can indirectly be involved in anticancer processes mainly via stimulating the immune system. Furthermore, the antioxidative ability of I. obliquus extracts can prevent generation of cancer cells. In this review, we highlight recent findings regarding mechanisms underlying the anticancer influence of I. obliquus, to provide a comprehensive landscape view of the actions of this mushroom in preventing cancer.
Article
Full-text available
Brown adipose tissue (BAT) plays a key role in energy homeostasis and thermogenesis in animals, conferring protection against diet-induced obesity and hypothermia through the action of uncoupling protein 1 (UCP1). Recent metabolic imaging studies using positron emission tomography computerized tomography (PET-CT) scanning have serendipitously revealed significant depots of BAT in the cervical-supraclavicular regions, demonstrating persistence of BAT beyond infancy. Subsequent cold-stimulated PET-CT studies and direct histological examination of adipose tissues have demonstrated that BAT is highly prevalent in adult humans. BAT activity correlates positively with increment of energy expenditure during cold exposure and negatively with age, body mass index, and fasting glycemia, suggesting regulatory links between BAT, cold-induced thermogenesis, and energy metabolism. Human BAT tissue biopsies express UCP1 and harbor inducible precursors that differentiate into UCP1-expressing adipocytes in vitro. These recent discoveries represent a metabolic renaissance for human adipose biology, overturning previous belief that BAT had no relevance in adult humans. They also have implications for the understanding of the pathogenesis and treatment of obesity and its metabolic sequelae.
Article
Although discussion of the obesity epidemic had become a cocktail party cliché, its impact on public health cannot be dismissed. In the past decade, cancer had joined the list of chronic debilitating diseases whose risk is substantially increased by hypernutrition. Here we discuss recent advances in understanding how obesity increases cancer risk and propose a unifying hypothesis according to which the major tumor-promoting mechanism triggered by hypernutrition is the indolent inflammation that takes place at particular organ sites, including liver, pancreas, and gastrointestinal tract. The mechanisms by which excessive fat deposition feeds this tumor-promoting inflammatory flame are diverse and tissue specific.
Article
Fractions of aqueous and water-alcohol extracts of the birch fungus Inonotus obliquus have antiviral effect against the human immunodeficiency virus type 1 (HIV-1). Antiviral properties of low toxic extracts were manifested in the concentration of 5.0 μg/ml upon simultaneous application with the virus in the lymphoblastoid cells culture MT-4. The extract of the birch fungus can be used for development of new antiviral drugs, inhibitors of HIV-replication when used both in the form of individual drugs and as a part of complex therapy.
Article
Living in an enriched environment (EE) decreases adiposity, increases energy expenditure, causes resistance to diet induced obesity, and induces brown-like (beige) cells in white fat via activating a hypothalamic-adipocyte axis. Here we report that EE stimulated VEGF expression in a fat depot-specific manner prior to the emergence of beige cells. The VEGF upregulation was independent of hypoxia but required intact sympathetic tone to the adipose tissue. Targeted adipose overexpression of VEGF reproduced the browning effect of EE. Adipose specific VEGF knockout or pharmacological VEGF blockade with antibodies abolished the induction of beige cell by EE. Hypothalamic BDNF stimulated by EE regulated the adipose VEGF expression and VEGF signaling was essential to the hypothalamic BDNF-induced WAT browning. Furthermore, VEGF signaling was essential to the beige cells induction by exercise, a β3 adrenergic agonist, and a PPARγ ligand, suggesting a common downstream pathway integrating diverse upstream mechanisms. Exploiting this pathway may offer potential therapeutic interventions to obesity and metabolic diseases.
Article
It was previously assumed that brown adipose tissue (BAT) is present in humans only for a short period following birth, the time in which mechanisms of generating heat by way of shivering are not yet developed. Although BAT is maximally recruited in early infancy, findings in recent years have led to a new consensus that metabolically active BAT remains present in most children and many adult humans. Evidence to date supports a slow and steady decline in BAT activity throughout life, with the exception of an intriguing spike in the prevalence and volume of BAT around the time of puberty that remains poorly understood. Because BAT activity is more commonly observed in individuals with a lower body mass index, an association seen in both adult and pediatric populations, there is the exciting possibility that BAT is protective against childhood and adult obesity. Indeed, the function and metabolic relevance of human BAT is currently an area of vigorous research. The goal of this review is to summarize what is currently known about changes that occur in BAT during various stages of life, with a particular emphasis on puberty and aging.
Article
Inonotus obliquus has been traditionally used for treatment of metabolic diseases; however, the mechanism remains to be elucidated. In this study, we found that the water-soluble melanin complex extracted from I. obliquus improved insulin sensitivity and reduced adiposity in high fat (HF)-fed obese mice. When the melanin complex was treated to 3T3-L1 adipocytes, insulin-stimulated glucose uptake was increased significantly, and its phosphoinositide 3-kinase-dependent action was proven with wortmannin treatment. Additionally, dose-dependent increases in Akt phosphorylation and glucose transporter 4 translocation into the plasma membrane were observed in melanin complex-treated cells. Adiponectin gene expression in 3T3-L1 cells incubated with melanin complex increased which was corroborated by increased AMP-activated protein kinase phosphorylation in HepG2 and C2C12 cells treated with conditioned media from the 3T3-L1 culture. Melanin complex-treated 3T3-L1 cells showed no significant change in expression of several lipogenic genes, whereas enhanced expressions of fatty acid oxidative genes were observed. Similarly, the epididymal adipose tissue of melanin complex-treated HF-fed mice had higher expression of fatty acid oxidative genes without significant change in lipogenic gene expression. Together, these results suggest that the water-soluble melanin complex of I. obliquus exerts antihyperglycemic and beneficial lipid-metabolic effects, making it a candidate for promising antidiabetic agent. Copyright © 2014 John Wiley & Sons, Ltd.
Article
A major goal of cancer immunology is to stimulate the generation of long-lasting, tumor antigen-specific immune responses that recognize and destroy tumor cells. This article discusses advances in thermal medicine with the potential to improve cancer immunotherapy. Accumulating evidence indicates that survival benefits are accorded to individuals who achieve an increase in body temperature (i.e. fever) following infection. Furthermore, accumulating evidence indicates that physiological responses to hyperthermia impact the tumor microenvironment through temperature-sensitive check-points that regulate tumor vascular perfusion, lymphocyte trafficking, inflammatory cytokine expression, tumor metabolism, and innate and adaptive immune function. Nevertheless, the influence of thermal stimuli on the immune system, particularly the antitum or immune response, remains incompletely understood. In fact, temperature is still rarely considered as a critical variable in experimental immunology. We suggest that more attention should be directed to the role of temperature in the regulation of the immune response and that thermal therapy should be tested in conjunction with immunotherapy as a multi-functional adjuvant that modulates the dynamics of the tumor microenvironment.